Status:

COMPLETED

Tailored PCA Based on Preoperative Pain Sensitivity

Lead Sponsor:

Seoul National University Hospital

Conditions:

Analgesia, Patient-Controlled

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

Opioids via intravenous patient-controlled analgesia (IV PCA) are widely used for postoperative pain control. However, effective pain control with minimized side effects of analgesic agents is still c...

Eligibility Criteria

Inclusion

  • patients scheduled to undergo elective gynecological surgery under general anesthesia
  • patients scheduled to use IV PCA for postoperative analgesia
  • patients with American Society of Anesthesiologists (ASA) physical status classification I, II, III

Exclusion

  • contraindication to fentanyl use
  • inability to communication
  • age less than 18 years, or more than 80 years
  • body weight less than 40kg, or more than 90kg
  • morbid cardiovascular disease
  • pregnancy

Key Trial Info

Start Date :

August 21 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 24 2017

Estimated Enrollment :

118 Patients enrolled

Trial Details

Trial ID

NCT03252977

Start Date

August 21 2017

End Date

November 24 2017

Last Update

December 19 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Seoul National University Hospital

Seoul, South Korea, 110-744